Cathie Wood's ARK Invest Buys Over 530,000 Shares of Fate Therapeutics

Investing

Published: July 8, 2021 9:05 am

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Wednesday. The fund bought over 530,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE), as the price of this ETF was down over 2% on the day. Note that this fund is up significantly in the past year.

Specifically, ARK Innovation ETF (NYSEARCA: ARKK) bought 535,305 shares of Fate Therapeutics. At Wednesday’s closing price, this would have valued this purchase at roughly $46.2 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 60% in the past year.

Here’s a look at the other purchases across the ARK ETFs:

Fund	Ticker	Company	Shares
ARKF	PATH	UiPath	279,284
ARKG	SGFY	Signify Health	53,916
ARKG	RXRX	Recursion Pharmaceuticals	204,752
ARKG	RPTX	Repare Therapeutics	18,190
ARKG	QSI	Quantum-Si	359,389
ARKG	MASS	908 Devices	47,945
ARKK	FATE	Fate Therapeutics	535,305
ARKK	COIN	Coinbase Global	20,165
ARKK	TSLA	Tesla	110,731
ARKQ	PATH	UiPath	135,228
ARKW	VUZI	Vuzix	521,151
ARKW	FTCH	Farfetch	599,955
ARKX	AVAV	Aerovironment	23,098
ARKX	PATH	UiPath	25,645

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge

In 20 Years, I Haven’t Seen A Cash Back Card This Good

After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers.

A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.

Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.